marches8 %The stock rose 8% during the session, despite a slightly declining CAC 40

Stifel raises Abivax target, stock soars in Paris

Stifel raised its price target on Abivax, boosting investor confidence.

Published 2sem1 sourceNotableupdated 4j

≈ 17sSpeed

The fact

The analyst also increased the probability of success for ongoing clinical trials.

The stock rose 8% during the session, despite a slightly declining CAC 40.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on July 2, 2026